◼ Archived
Business
🔮 Newsylist predicts: still trending tomorrow low confidence — graded ✗ wrong
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
2sources
2articles
1velocity
+0%since first seen
56d agofirst detected
Text:
🤖 AI Dossier
The reporting (2)
-
-
AstraZeneca's tozorakimab cuts COPD exacerbations in Phase III studies firstwordpharma.com · 56d ago broke it first
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📊 AUDIENCE & LONGEVITY PULSE
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
Related trends
▲ Peaking
Business
Half of Bay Area would be exempt from gas water heater ban, officials now say. Here’s who’s still on the hook
▲ Peaking
Business
There's a 99% Chance That Democrats Retake the House, and History Says This Shift Will Have a Huge Impact on Stocks
▲ Peaking
Business
AI Inference Startup Fal Raises Capital at $16 Billion Valuation
🔥 Breakout ↑ Rising
Business
Democrats’ Victory to Add Volatility to AI Trade
🔥 Breakout ↑ Rising
Business
Dow futures surge 800 points after decisive win by Democrats in U.S. midterms: Live updates
▲ Peaking
Business